iCap et LEXI sont déployés sur les six chaînes d’Europe centrale et orientale de CME LONDRES, 04 déc. 2024 (GLOBE NEWSWIRE) — AI-Media, leader mondial en matière de sous-titrage généré par l’IA en direct et en différé et de technologie linguistique, a le plaisir d’annoncer un contrat stratégique de 5 ans
iCap et LEXI sont déployés sur les six chaînes d’Europe centrale et orientale de CME LONDRES, 04 déc. 2024 (GLOBE NEWSWIRE) — AI-Media, leader mondial en matière de sous-titrage généré par l’IA en direct et en différé et de technologie linguistique, a le plaisir d’annoncer un contrat stratégique de 5
iCap and LEXI roll out to CME’s six Central and Eastern European stations AI-Media and CME Sign 5-Year Agreement LONDON, Dec. 04, 2024 (GLOBE NEWSWIRE) — AI-Media, a global leader in live and recorded AI captioning and language technology, is delighted to announce a strategic 5-year agreement with Central European
iCap and LEXI roll out to CME’s six Central and Eastern European stations AI-Media and CME Sign 5-Year Agreement AIM Signs Landmark 5-Year Deal with Central European Media Enterprises (CME). LONDON, Dec. 04, 2024 (GLOBE NEWSWIRE) — AI-Media, a global leader in live and recorded AI captioning and language technology,
Two-day event will preview Mavenir’s strategic initiatives and forward-looking roadmap to invited international audience of analysts, customers and partners RICHARDSON, Texas, Dec. 04, 2024 (GLOBE NEWSWIRE) — Mavenir, the cloud-native network infrastructure provider building the future of networks, will hold its annual analyst event from December 11 – 12, 2024
Two-day event will preview Mavenir’s strategic initiatives and forward-looking roadmap to invited international audience of analysts, customers and partners RICHARDSON, Texas, Dec. 04, 2024 (GLOBE NEWSWIRE) — Mavenir, the cloud-native network infrastructure provider building the future of networks, will hold its annual analyst event from December 11 – 12, 2024
LAKE TAHOE, Nev., Dec. 03, 2024 (GLOBE NEWSWIRE) — 2ONE Labs Inc., is pleased to have received ‘Acceptance’ of a second Premarket Tobacco Product Application (PMTA) for additional flavored 2ONE® nicotine product styles submitted to the U.S. Food and Drug Administration (FDA). Welcoming receipt of this additional FDA ‘Acceptance’ notification,
LAKE TAHOE, Nev., Dec. 03, 2024 (GLOBE NEWSWIRE) — 2ONE Labs Inc., is pleased to have received ‘Acceptance’ of a second Premarket Tobacco Product Application (PMTA) for additional flavored 2ONE® nicotine product styles submitted to the U.S. Food and Drug Administration (FDA). Welcoming receipt of this additional FDA ‘Acceptance’ notification, Vincent
Promoting revolutionary values and uniting movements for South Africa’s economic freedom.
Enter your email address below to subscribe to my newsletter
